[1]
|
Ferguson, M.K., DeMeester, T.R., DesLauriers, J., Little, A.G., Piraux, M., et al. (1985) Diagnosis and Management of Synchronous Lung Cancers. The Journal of Thoracic and Cardiovascular Surgery, 89, 378-385.
|
[2]
|
Verhagen, A.F., van de Wal, H.J., Cox, A.L. and Lacquet, L.K. (1989) Surgical Treatment of Multiple Primary Lung Cancers. The Journal of Thoracic and Cardiovascular Surgery, 37, 107-111. http://dx.doi.org/10.1055/s-2007-1013919
|
[3]
|
Lam, S., Macauley, C. and Palcic, B. (1993) Detection and Localization of Early Lung Cancer by Imaging Techniques. Chest, 103, 12-14. http://dx.doi.org/10.1378/chest.103.1_Supplement.12S
|
[4]
|
Woolner, L.B., Fontana, R.S. and Cortese, D.A. (1984) Roentogenographically Occult Lung Cancer; Pathologic Findings and Frequency of Multicentricity during a 10-Year Period. Mayo Clinic Proceedings, 59, 453-466. http://dx.doi.org/10.1016/S0025-6196(12)60434-0
|
[5]
|
Van Rens, M.T., Zanen, P., Brutel de La Riviere, A., Elbers, H.R., van Swieten, H.A., et al. (2000) Survival in Synchronous versus Single Lung; Upstaging Better Reflects Prognosis. Chest, 118, 952-958. http://dx.doi.org/10.1378/chest.118.4.952
|
[6]
|
Nakata, M., Sawada, S., Yamashita, M., Saeki, H., Kurita, A., Takashima, S., et al. (2004) Surgical Treatment for Multiple Primary Adenocarcinoma of the Lung. Annals of Thoracic Surgery, 78, 1194-1199. http://dx.doi.org/10.1016/j.athoracsur.2004.03.102
|
[7]
|
Nakata, M., Saeki, H., Takata, I., Segawa,Y., Mogami, H., et al. (2002) Focal Ground-Glass Opacity Detected by Low-Dose Helical CT. Chest, 121, 1464-1467. http://dx.doi.org/10.1378/chest.121.5.1464
|
[8]
|
Hiramatsu, M., Inagaki, T., Inagaki, T., Matsui, Y., Satoh, Y., Okumura, S., et al. (2008) Pulmonary Ground-Glass Opacity (GGO) Lesions-Large Size and a History of Lung Cancer Are Risk Factors for Growth. Journal of Thoracic Oncology, 3, 1245-1250. http://dx.doi.org/10.1097/JTO.0b013e318189f526
|
[9]
|
Aoki, T., Nakata, H., Watanabe, H., Nakamura, K., Kasai, T., Hashimoto, H., et al. (2000) Evolution of Peripheral Lung Adenocarcinomas: CT Findings Correlated with Histology and Tumor Doubling Time. American Journal of Roentgenology, 174, 763-768. http://dx.doi.org/10.2214/ajr.174.3.1740763
|
[10]
|
Hasegawa, M., Sone, S., Takashima, S., Li, F., Yang, Z.G., Maruyama, Y., et al. (2000) Growth Rate of Small Lung Cancers Detected on Mass CT Screening. The British Journal of Radiology, 73, 1252-1259. http://dx.doi.org/10.1259/bjr.73.876.11205667
|
[11]
|
Libby, D.M., Smith, J.P., Altorki, N.K., Pasmantier, M.W., Yankelevitz, D. and Henschke, C.I. (2004) Managing the Small Pulmonary Nodule Discovered by CT. Chest, 125, 1522-1529. http://dx.doi.org/10.1378/chest.125.4.1522
|
[12]
|
Martini, N. and Melamed, M.R. (1975) Multiple Primary Lung Cancers. Journal of Thoracic and Cardiovascular Surgery, 70, 606-612.
|
[13]
|
Dobashi, K., Sugio, K., Osaki, T., Oka, T. and Yasumoto, K. (1997) Micrometastatic p53-Positive Cells in the Lymph Nodes of Non-Small-Cell Lung Cancer: Prognostic Significance. Journal of Thoracic and Cardiovascular Surgery, 114, 339-346. http://dx.doi.org/10.1016/S0022-5223(97)70178-8
|
[14]
|
Taga, S., Osaki, T., Ohgami, A., Imoto, H., Yoshimatsu, T., Yoshio, I., et al. (1997) Prognostic Value of the Immunohistochemical Detection of p16INK4 Expression in Non-Small Cell Lung Carcinoma. Cancer, 80, 389-395. http://dx.doi.org/10.1002/(SICI)1097-0142(19970801)80:3<389::AID-CNCR6>3.0.CO;2-N
|
[15]
|
Tsukamoto, S., Sugio, K., Sakada, T., Ushijima, C., Yamazaki, K. and Sugimachi, K. (2001) Reduced Expression of Cell-Cycle Regulator p27Kip1 Correlates with a Shortened Survival in Non-Small Cell Lung Cancer. Lung Cancer, 34, 83-90. http://dx.doi.org/10.1016/S0169-5002(01)00216-1
|
[16]
|
Sugio, K., Ishida, T., Yokoyama, H., Inoue, T., Sugimachi, K. and Sasazuki, T. (1992) Ras Gene Mutations as a Prognostic Marker in Adenocarcinoma of the Human Lung without Lymph-Node Metastasis. Cancer Research, 52, 2903-2906.
|
[17]
|
Osaki, T., Mitsudomi, T., Oyama, T., Nakanishi, R. and Yasumoto, K. (1995) Serum Level and Tissue Expression of c-erbB-2 Protein in Lung Adenocarcinoma. Chest, 108, 157-162. http://dx.doi.org/10.1378/chest.108.1.157
|
[18]
|
Mitsudomi, T., Hamajima, N., Ogawa, M. and Takahashi, T. (2000) Prognostic Significance of p53 Alterations in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis. Clinical Cancer Research, 6, 4055-4063.
|
[19]
|
Otterson, G.A., Kratzke, R.A., Coxon, A., Kim, Y.M. and Kaye, F.J. (1994) Absence of p16INK4 Protein Is Restricted to the Subset of Lung Cancer Lines that Retains Wildtype RB. Oncogene, 9, 3375-3378.
|